TriSalus Life Sciences (NASDAQ:TLSI) announced its Q4 earnings on Thursday, March 5, 2026 at 04:01 PM.
Here's a breakdown of the earnings report.
Earnings
TriSalus Life Sciences missed estimated earnings by -61.54%, reporting an EPS of $-0.21 versus an estimate of $-0.13.
Revenue was up $4.94 million from the same period last year.
Performance in Previous Earnings
Last quarter the company missed on EPS by $0.79 which was followed by a 3.87% increase in the share price the next day.
Here's a look at TriSalus Life Sciences's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.17 | -0.22 | -0.20 | -0.35 |
| EPS Actual | -0.96 | -0.27 | -0.39 | -0.40 |
| Revenue Estimate | 11.65M | 10.67M | 9.04M | 8.24M |
| Revenue Actual | 11.57M | 11.21M | 9.17M | 8.26M |
To track all earnings releases for TriSalus Life Sciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to comment